Neurogastrx
Pharmaceuticals, 600 Unicorn Park Dr, Woburn, Massachusetts, 01801, United States, 11-50 Employees
Phone Number: 78********
Who is NEUROGASTRX
We are a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) di...
Read More
-
Headquarters: 600 Unicorn Park Dr, Woburn, Massachusetts, 01801, United States
-
Date Founded: 2012
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from NEUROGASTRX
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Neurogastrx
Answer: Neurogastrx's headquarters are located at 600 Unicorn Park Dr, Woburn, Massachusetts, 01801, United States
Answer: Neurogastrx's phone number is 78********
Answer: Neurogastrx's official website is https://neurogastrx.com
Answer: Neurogastrx's revenue is $1 Million to $5 Million
Answer: Neurogastrx's SIC: 2834
Answer: Neurogastrx has 11-50 employees
Answer: Neurogastrx is in Pharmaceuticals
Answer: Neurogastrx contact info: Phone number: 78******** Website: https://neurogastrx.com
Answer: We are a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases. We believe that the lack of innovation and limited treatment options for GI patients present us with a significant opportunity to address this large unmet medical need. Initially, we are focused on pursuing indications for the treatment of patients suffering from erosive esophagitis (EE) and gastroparesis. We believe our approach, which is targeted to the gastroenterology community, combined with the experience of our management team in developing and commercializing medicines in the GI space, positions us to identify, develop and efficiently bring to market solutions for GI diseases with limited innovation and/or treatment options.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month